{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T06:12:32Z","timestamp":1788415952699,"version":"build-2803163510"},"reference-count":18,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T00:00:00Z","timestamp":1788393600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p>\n                    Hereditary angioedema (HAE) is a rare genetic disorder typically characterized by cutaneous and submucosal edema. Cases presenting exclusively with gastrointestinal symptoms, devoid of concurrent or historical cutaneous or upper airway manifestations, are uncommon. This atypical presentation poses a considerable diagnostic challenge and often leads to a marked delay in diagnosis, particularly in patients without a family history. We report the case of a 28-year-old female with an over 6-year history of recurrent, self-limiting abdominal pain. During a severe attack, abdominal computed tomography angiography (CTA) revealed jejunal wall edema and ascites, accompanied by a dramatic surge in D-dimer (&amp;gt;20.00\u202fmg\/L FEU) and fibrin degradation products (FDP &amp;gt;120.00\u202fmg\/L), closely mimicking mesenteric ischemia. However, a retrospective review of medical history identified the persistent consumption of complement C4 (0.03\u20130.05\u202fg\/L). Subsequent testing showed a functional C1 esterase inhibitor (fC1-INH) level of &amp;lt;7.0% and a C1 esterase inhibitor (C1-INH) antigen level of 6.81\u202f\u03bcg\/mL, confirming type 1 HAE. Whole-exome sequencing (WES) identified the nonsense variant NM_000062.3:c.990C&amp;gt;A, p.(Tyr330Ter), in\n                    <jats:italic>SERPING1<\/jats:italic>\n                    . The variant was not detected in either biological parent, supporting a\n                    <jats:italic>de novo<\/jats:italic>\n                    origin. Under the American College of Medical Genetics and Genomics (ACMG) and the Association for Molecular Pathology (AMP) framework, it was classified as pathogenic on the basis of PVS1 and PS2. An abdominal attack in May 2025 resolved rapidly after icatibant administration. Long-term prophylaxis (LTP) with lanadelumab was subsequently initiated following an individualized shared decision-making process. No breakthrough attacks or treatment related adverse events occurred from June 2025 through June 2026. This report highlights that HAE should be considered in patients with recurrent, unexplained, self-limiting abdominal pain, and C4 should be included in the initial evaluation. A negative family history does not exclude HAE.\n                  <\/jats:p>","DOI":"10.3389\/fmed.2026.1936529","type":"journal-article","created":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T05:14:43Z","timestamp":1788412483000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Isolated gastrointestinal hereditary angioedema associated with a pathogenic SERPING1 variant arising de novo: a case report"],"prefix":"10.3389","volume":"13","author":[{"given":"Ziyu","family":"Yuan","sequence":"first","affiliation":[{"name":"The Second Clinical College of Guangzhou University of Chinese Medicine","place":["Guangzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weipeng","family":"Lin","sequence":"additional","affiliation":[{"name":"The Second Clinical College of Guangzhou University of Chinese Medicine","place":["Guangzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Zheng","sequence":"additional","affiliation":[{"name":"The Second Clinical College of Guangzhou University of Chinese Medicine","place":["Guangzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xizi","family":"Yuan","sequence":"additional","affiliation":[{"name":"The First Clinical College of Guangzhou University of Chinese Medicine","place":["Guangzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Luo","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine","place":["Guangzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingyu","family":"Fu","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine","place":["Guangzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiyan","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine","place":["Guangzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,3]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.1111\/all.15214","article-title":"The international WAO\/EAACI guideline for the management of hereditary angioedema-the 2021 revision and update","volume":"77","author":"Maurer","year":"2022","journal-title":"Allergy"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.jaip.2020.08.046","article-title":"US HAEA medical advisory board 2020 guidelines for the Management of Hereditary Angioedema","volume":"9","author":"Busse","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1111\/j.1572-0241.2006.00492.x","article-title":"Symptoms, course, and complications of abdominal attacks in hereditary angioedema due to C1 inhibitor deficiency","volume":"101","author":"Bork","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1159\/000545808","article-title":"Expert consensus on the diagnosis and treatment of hereditary angioedema in China (2024 edition)","volume":"187","author":"Xu","year":"2026","journal-title":"Int Arch Allergy Immunol"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"131","DOI":"10.2500\/aap.2021.42.210001","article-title":"Recurrent and acute abdominal pain as the main clinical manifestation in patients with hereditary angioedema","volume":"42","author":"Cao","year":"2021","journal-title":"Allergy Asthma Proc"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1002\/humu.23917","article-title":"SERPING1 mutation update: mutation spectrum and C1 inhibitor phenotypes","volume":"41","author":"Ponard","year":"2020","journal-title":"Hum Mutat"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1002\/humu.23626","article-title":"Recommendations for interpreting the loss of function PVS1 ACMG\/AMP variant criterion","volume":"39","author":"Abou Tayoun","year":"2018","journal-title":"Hum Mutat"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.iac.2017.04.001","article-title":"Pathogenesis of hereditary angioedema: the role of the bradykinin-forming Cascade","volume":"37","author":"Kaplan","year":"2017","journal-title":"Immunol Allergy Clin N Am"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"101335","DOI":"10.1016\/j.waojou.2026.101335","article-title":"The 2025 WAO guidelines for the classification, diagnosis, and treatment of hereditary angioedema, with consideration of worldwide disparities","volume":"19","author":"V\u00e1zquez","year":"2026","journal-title":"World Allergy Organ J"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"1400526","DOI":"10.3389\/fimmu.2024.1400526","article-title":"Systemic inflammation biomarkers during angioedema attacks in hereditary angioedema","volume":"15","author":"Gil-Serrano","year":"2024","journal-title":"Front Immunol"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.3390\/biom14101298","article-title":"Unveiling the complexities of hereditary angioedema","volume":"14","author":"Tutunaru","year":"2024","journal-title":"Biomolecules"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"2896","DOI":"10.1016\/j.jaip.2022.07.035","article-title":"Prospective study on the efficacy and impact of Cascade screening and evaluation of hereditary angioedema (CaSE-HAE)","volume":"10","author":"Wong","year":"2022","journal-title":"J Allergy Clin Immunol Pract"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s12948-021-00141-0","article-title":"Hereditary angioedema due to C1 inhibitor deficiency in Belarus: epidemiology, access to diagnosis and seven novel mutations in SERPING1 gene","volume":"19","author":"Guryanova","year":"2021","journal-title":"Clin Mol Allergy"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1007\/s12328-025-02147-6","article-title":"A rare case of hereditary angioedema with exclusive gastrointestinal symptoms and no cutaneous involvement","volume":"18","author":"Wu","year":"2025","journal-title":"Clin J Gastroenterol"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1007\/s12325-022-02401-0","article-title":"Hereditary angioedema: diagnosis, clinical implications, and pathophysiology","volume":"40","author":"Sinnathamby","year":"2023","journal-title":"Adv Ther"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"2315","DOI":"10.1016\/j.jaip.2023.04.017","article-title":"Hereditary angioedema: a review of the current and evolving treatment landscape","volume":"11","author":"Betschel","year":"2023","journal-title":"J Allergy Clin Immunol Pract"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1002\/pd.6144","article-title":"Parental mosaicism for apparent de novo genetic variants: scope, detection, and counseling challenges","volume":"42","author":"Zemet","year":"2022","journal-title":"Prenat Diagn"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1936529\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T05:14:44Z","timestamp":1788412484000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1936529\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,3]]},"references-count":18,"alternative-id":["10.3389\/fmed.2026.1936529"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2026.1936529","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,3]]},"article-number":"1936529"}}